Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.

Ramakrishnan, Seema; Baskaran, Prabu; Talwar, Badrinath; Venkatesh, Rengaraj

doi:10.1097/APO.0000000000000089

Record: found
Abstract: found
Article: not found

Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.

Author(s): Seema Ramakrishnan, Prabu Baskaran, Badrinath Talwar, Rengaraj Venkatesh

Publication date: 2015-08-01

Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Publisher: Ovid Technologies (Wolters Kluwer Health)

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study aimed to compare the short-term efficacy of 0.1% nepafenac with that of 0.4% ketorolac tromethamine in patients with low risk factors for cystoid macular edema (CME) undergoing phacoemulsification.